BR9707785A - Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas - Google Patents
Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinasInfo
- Publication number
- BR9707785A BR9707785A BR9707785A BR9707785A BR9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccines
- parapoxvirus
- foreign dna
- dna preparation
- containing foreign
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24241—Use of virus, viral particle or viral elements as a vector
- C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19607458 | 1996-02-28 | ||
| DE19639601A DE19639601A1 (de) | 1996-02-28 | 1996-09-26 | Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen |
| DE9700729 | 1997-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9707785A true BR9707785A (pt) | 1999-07-27 |
Family
ID=26023280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9707785A BR9707785A (pt) | 1996-02-28 | 1997-02-17 | Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6365393B1 (pt) |
| EP (1) | EP0886679B1 (pt) |
| JP (1) | JP2000507092A (pt) |
| CN (1) | CN1217027A (pt) |
| AT (1) | ATE364090T1 (pt) |
| AU (1) | AU718141B2 (pt) |
| BR (1) | BR9707785A (pt) |
| CA (1) | CA2247336C (pt) |
| DE (1) | DE59712852D1 (pt) |
| DK (1) | DK0886679T3 (pt) |
| ES (1) | ES2287949T3 (pt) |
| HU (1) | HUP9901035A3 (pt) |
| IL (1) | IL125797A0 (pt) |
| NO (1) | NO983946L (pt) |
| NZ (1) | NZ331556A (pt) |
| PL (1) | PL190401B1 (pt) |
| SK (1) | SK120098A3 (pt) |
| TR (1) | TR199801702T2 (pt) |
| WO (1) | WO1997032029A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9708401A (pt) * | 1996-03-29 | 2000-01-04 | Univ Otago | Vetores de vìrus de para-varìola |
| DK2016951T3 (da) * | 1998-03-17 | 2012-09-24 | Genentech Inc | VEGF- og BMP1-homologe polypeptider |
| EP1126863B1 (en) * | 1998-11-02 | 2006-05-03 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| CN1455674B (zh) * | 2000-07-11 | 2019-03-29 | 艾库里斯有限及两合公司 | 绵羊副痘病毒菌株用于制备抗病毒药物和抗癌药物的用途 |
| US6752995B2 (en) * | 2002-04-15 | 2004-06-22 | Board Of Regents, The University Of Texas System | Nucleic acid and polypeptide sequences useful as adjuvants |
| WO2003049683A2 (en) | 2001-12-07 | 2003-06-19 | Bayer Pharmacueticals Corporation | Use of parapox b2l protein to treat cancer and modify immune responses |
| JP4897677B2 (ja) * | 2004-07-13 | 2012-03-14 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト | Ｈｉｖ／ａｉｄｓの処置用の他の抗ウイルス剤と組み合わせたパラポックスウイルス |
| EA201270764A1 (ru) * | 2010-04-29 | 2013-06-28 | Римзер Фарма Гмбх | Парапоксвирус, экспрессирующий vp60 главный белок капсида вируса геморрагического заболевания кроликов |
| AU2011254315B2 (en) | 2010-05-21 | 2015-05-14 | Zoetis Services Llc | Parapoxvirus vectors containing rabies virus antigen |
| EP2595652A1 (en) | 2010-07-20 | 2013-05-29 | Ah Usa 42 Llc | Parapoxvirus vectors |
| CA2879443A1 (en) | 2012-07-19 | 2014-01-23 | Zoetis Llc | Bovine influenza virus compositions |
| AU2013295770A1 (en) | 2012-07-27 | 2015-01-29 | Zoetis Services Llc | Tick toxin compositions |
| DE102015111756A1 (de) * | 2015-07-20 | 2017-01-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Rekombinanter Orf-Virus-Vektor |
| CA2995101A1 (en) | 2015-08-14 | 2017-02-23 | Zoetis Services Llc | Mycoplasma bovis compositions |
| US11013798B2 (en) | 2016-03-21 | 2021-05-25 | South Dakota Board Of Regents | Orf virus-based platform for vaccine delivery |
| MX2020009262A (es) | 2018-03-07 | 2021-01-08 | Transgene | Vectores de parapoxvirus. |
| WO2024062098A1 (en) | 2022-09-23 | 2024-03-28 | Transgene | Recombinant pseudocowpox virus encoding an interleukin-12 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DK0758397T3 (da) * | 1994-04-29 | 2005-10-10 | Baxter Healthcare Sa | Rekombinante poxvira med fremmede polynucleotider i essentielle regioner |
-
1997
- 1997-02-17 AU AU17257/97A patent/AU718141B2/en not_active Ceased
- 1997-02-17 ES ES97904453T patent/ES2287949T3/es not_active Expired - Lifetime
- 1997-02-17 CA CA002247336A patent/CA2247336C/en not_active Expired - Lifetime
- 1997-02-17 DK DK97904453T patent/DK0886679T3/da active
- 1997-02-17 JP JP9530549A patent/JP2000507092A/ja active Pending
- 1997-02-17 IL IL12579797A patent/IL125797A0/xx unknown
- 1997-02-17 EP EP97904453A patent/EP0886679B1/de not_active Expired - Lifetime
- 1997-02-17 US US09/125,642 patent/US6365393B1/en not_active Expired - Lifetime
- 1997-02-17 PL PL97328870A patent/PL190401B1/pl not_active IP Right Cessation
- 1997-02-17 NZ NZ331556A patent/NZ331556A/xx unknown
- 1997-02-17 DE DE59712852T patent/DE59712852D1/de not_active Expired - Lifetime
- 1997-02-17 BR BR9707785A patent/BR9707785A/pt not_active Application Discontinuation
- 1997-02-17 HU HU9901035A patent/HUP9901035A3/hu unknown
- 1997-02-17 CN CN97194139A patent/CN1217027A/zh active Pending
- 1997-02-17 WO PCT/EP1997/000729 patent/WO1997032029A1/de active IP Right Grant
- 1997-02-17 SK SK1200-98A patent/SK120098A3/sk unknown
- 1997-02-17 TR TR1998/01702T patent/TR199801702T2/xx unknown
- 1997-02-17 AT AT97904453T patent/ATE364090T1/de active
-
1998
- 1998-08-27 NO NO983946A patent/NO983946L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE364090T1 (de) | 2007-06-15 |
| SK120098A3 (en) | 1999-03-12 |
| IL125797A0 (en) | 1999-04-11 |
| DK0886679T3 (da) | 2007-09-24 |
| PL328870A1 (en) | 1999-03-01 |
| CA2247336C (en) | 2008-06-17 |
| DE59712852D1 (de) | 2007-07-19 |
| US6365393B1 (en) | 2002-04-02 |
| AU718141B2 (en) | 2000-04-06 |
| AU1725797A (en) | 1997-09-16 |
| PL190401B1 (pl) | 2005-12-30 |
| NO983946L (no) | 1998-10-22 |
| EP0886679B1 (de) | 2007-06-06 |
| CN1217027A (zh) | 1999-05-19 |
| HUP9901035A3 (en) | 2001-01-29 |
| EP0886679A1 (de) | 1998-12-30 |
| NZ331556A (en) | 2000-05-26 |
| HUP9901035A2 (hu) | 1999-07-28 |
| TR199801702T2 (xx) | 1998-12-21 |
| NO983946D0 (no) | 1998-08-27 |
| JP2000507092A (ja) | 2000-06-13 |
| ES2287949T3 (es) | 2007-12-16 |
| WO1997032029A1 (de) | 1997-09-04 |
| CA2247336A1 (en) | 1997-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9707785A (pt) | Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas | |
| ATE404220T1 (de) | Rekombinierte pockenvirus-tollwut zusammensetzung und kombinierte zusammensetzungen und deren verwendung | |
| BR9605153B1 (pt) | vacina de combinação, e, kit de vacinação. | |
| MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
| NO20013701L (no) | HER-2/neu-fusjonsproteiner | |
| BR0014282A (pt) | Vacinas | |
| DE69936948D1 (de) | Virusenthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten | |
| BRPI9912663B8 (pt) | vacina contra cáncer e polipeptìdeo. | |
| NO944377L (no) | Kjölemiddelblandinger | |
| BR9807873A (pt) | Vacinas de flavivìrus quiméricos | |
| DE69532106D1 (de) | Maltose Phospharylase, Trehalose Phophorylase, Plesiomonasstamm, und Herstellung von Trehalose | |
| DK0704499T3 (da) | Højtransparente, gule jernoxidpigmenter, fremgangsmåde til deres fremstilling samt deres anvendelse | |
| YU36698A (sh) | Parapoks-virusi koji sadrže stranu dnk, njihovo dobijanje i njihova primena u vakcinama | |
| DK0704501T3 (da) | Højtransparente, røde jernoxidpigmenter, fremgangsmåde til deres fremstilling og anvendelse | |
| AU1815899A (en) | Method and composition to enhance the efficacy of a vaccine using chemokines | |
| HUP0001991A2 (hu) | Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák | |
| ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
| ATE381351T1 (de) | Anwendung des herpes simplex virus glykoproteins- d zur unterdrückung von immunantworten | |
| DE69401437D1 (de) | Verbesserte schutzmembrane, insbesondere zur verkleidung von wänden und decken | |
| DK0704498T3 (da) | Særdeles højtransparente, gule jernoxidpigmenter, fremgangsmåde til deres fremstilling samt deres anvendelse | |
| NZ511168A (en) | Recombinant CELO virus and CELO virus DNA | |
| DE3671603D1 (de) | Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose. | |
| NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
| FR2671974B1 (pt) | ||
| NL300165I1 (nl) | Babesiavaccine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: BAYER HEALTHCARE AG (DE) Free format text: TRANSFERIDO DE: BAYER AKITIENGESELLSCHAFT |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI. |